Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4003024 | American Journal of Ophthalmology | 2012 | 9 Pages |
Abstract
Recommendations arising from a root cause analysis of infectious endophthalmitis outbreaks should focus on the procedures used by pharmacies to compound bevacizumab. Microbial contamination of bevacizumab-containing syringes prepared from the same vial of drug can be avoided by using a single vial of bevacizumab for each eye or by following strict adherence to United States Pharmacopoeia Chapter 797 requirements when compounding a single vial of bevacizumab into multiple syringes.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Serafin Gonzalez, Philip J. Rosenfeld, Michael W. Stewart, Jennifer Brown, Steven P. Murphy,